Company: HYEX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001096906-25-001303
Chunk: 15

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 7
Chunk 15
---
 of $100,000, offset in part by our decrease in inventory of $254,337, lease liability-long-term of $121,761, and warrants issued for services of $95,152. Our net cash used in operating activities for the six months ended June 30, 2024, consisted of our net loss of $747,758, offset in part by change in fair value on derivative liability of $582,472, decrease in inventory of $306,661, and warrants issued for services of $193,168.

Investing Activities

We had cash used in investing activities of $19,302 for the six months ended June 30, 2025, consisting entirely of a fixed asset purchase. We had zero cash used in investing activities for the six months ended June 30, 2024.

Financing Activities

Our net cash provided by financing activities for the six months ended June 30, 2025 was $30,539, compared to $(59,020) for the six months ended June 30, 2024. Our net cash provided by financing activities consisted of proceeds from the issuance of notes payable of $160,000, offset by repayment of convertible debt of $83,437, repayment of notes payable-related party of $37,524, and repayment of notes payable of $8,498.

ITEM 3Quantitative and Qualitative Disclosures About Market Risk 

As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 4Controls and Procedures 

(a)Disclosure Controls and Procedures  

We conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, as of June 30, 2025, to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities Exchange Commission’s rules and forms, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief